|
WO2009011697A1
|
|
Rna oligonucleotides targeting ebv and host genes and their use for treatment of nasopharyngeal carcinomas
|
|
CN1840203A
|
|
The oligonucleotide drug of control influenza infection
|
|
CN1718194A
|
|
Oligonucleotide medicine for treating myophagism
|
|
WO0123620A2
|
|
Arrays with modified oligonucleotide and polynucleotide compositions
|
|
AU5269600A
|
|
Arrays with modified oligonucleotide and polynucleotide compositions
|
|
EP1140966A1
|
|
Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
|
|
EP1141278A2
|
|
Therapeutic pde4d phosphodiesterase inhibitors
|
|
US6844151B1
|
|
Methods for production of arrays with modified oligonucleotide and polynucleotide compositions
|
|
US6087112A
|
|
Arrays with modified oligonucleotide and polynucleotide compositions
|
|
US6211162B1
|
|
Pulmonary delivery of protonated/acidified nucleic acids
|
|
US6627215B1
|
|
Devices for improved wound management
|
|
US6211349B1
|
|
Protonated/acidified nucleic acids and methods of use
|
|
US5989912A
|
|
Three component chimeric antisense oligonucleotides
|
|
US5849902A
|
|
Three component chimeric antisense oligonucleotides
|
